Drs. Fatemeh Ardeshir-Larijani and Mohamed Abazeed discuss a validated AI model that can predict how patients with advanced NSCLC will respond to immunotherapy.
The post Q&A: Validated AI Model Could Guide Real-World NSCLC Decisions first appeared on Physician’s Weekly.
